$UCLE US Nuclear Announces a Significant Improvement in 3rd

New Post Public Reply Private Reply Replies (0) Message Board
louied91
165
$UCLE US Nuclear Announces a Significant Improvement in 3rd Quarter Financials

https://www.globenewswire.com/news-release/20...cials.html

LOS ANGELES, Nov. 19, 2024 (GLOBE NEWSWIRE) -- US Nuclear Corp. (OTC: UCLE) is pleased to announce they have made significant progress in reducing current liabilities by over $3 million in the 3rd quarter, while projecting a swing in profitability of over $1 million from the 3rd quarter of 2023. Results will be released with the 3rd quarter results later this month.

In conjunction with these efforts, the Company has increased pricing by 5.5% effective this month, and has begun a cost reduction program to reduce expenses 15%, or $100k per quarter in order to facilitate the road back to profitability.

Chamberlain Capital Partners have been retained to assist in these efforts by raising additional capital to fund the increased level of sales, and introduce marketing programs which will educate potential customers about the 50-year history of the Company in the nuclear-monitoring space. New initiatives will introduce monitoring devices that can identify and monitor the worst emitters of methane and carbon dioxide from the population of 5 million uncapped and abandoned oil wells in the US.

In 2025 the Company will introduce monitors to monitor the level of PFAS “forever chemicals,” a health threat area estimated to be many times larger than those created by both asbestos and tobacco combined.

For sales and product information call Bob Goldstein at (818) 472-7071, or email Mark Kohn at mark.kohn@usnuclear.com. For Investor information call Jack Lennon at Chamberlain Capital (508) 360-8407 or jjlennon@comcast.net.

US Nuclear Corp (UCLE) Stock Research Links

UCLE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Cultural Excellence: Fukuoka Prize 2025 Laureates Revealed

Updated Category News Views 360

Fukuoka City Announces 2025 Fukuoka Prize Winners Fukuoka City has revealed the recipients of the prestigious Fukuoka Prize for 2025, honoring remarkable individuals in the field of Asian studies and the arts. This award is presented to those who excel in preserving and enhancing the rich tapestry of Asian culture. Fukuoka City is dedicated to celebrating these...

Continue Reading
Investors Unite: Join Flywire Corporation Legal Action Today

Updated Category News Views 168

Flywire Corporation Investors Take Action Against Securities Fraud In a moment of reckoning, investors in Flywire Corporation are seizing the opportunity to join a class action lawsuit concerning alleged securities fraud. The filing of this lawsuit has been initiated to hold accountable those responsible for misleading investors during a specified period, marking a...

Continue Reading
Venus Concept Secures $2.7 Million for Growth and Innovation

Updated Category News Views 323

Venus Concept Raises Significant Funds for Future Endeavors Venus Concept Inc. (NASDAQ: VERO), a renowned name in the global medical aesthetic technology arena, recently achieved a noteworthy milestone by closing a registered direct offering that provided around $1.57 million in gross proceeds. The offering consisted of 386,700 shares of common stock, sold at $4.06 each,...

Continue Reading
Revolutionary RAGE: UPENDS Launches Game-Changing Vape System

Updated Category News Views 211

UPENDS Unveils Groundbreaking Open Pod Vape System In a remarkable stride forward for the vaping industry, UPENDS has launched their revolutionary RAGE open pod system, designed to transform how enthusiasts experience vaping. As the European market continues to evolve, this cutting-edge device positions itself as a leader in user-centric innovation and compliance. The...

Continue Reading
Investors Target Kyverna Therapeutics: Key Details You Need

Updated Category News Views 101

Understanding Ongoing Investigations at Kyverna Therapeutics As the financial landscape continues to evolve, investors find themselves keenly interested in the developments surrounding Kyverna Therapeutics, Inc. (NASDAQ: KYTX). With a prominent law firm engaged in scrutinizing potential claims, the situation promises vital updates for concerned stakeholders. Faruqi &...

Continue Reading